Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1590 results found

2026 ∙ WHO

WHO position paper on COVID-19 vaccines - July 2026

  • WHO
  • COVID-19
Download:
2026 ∙ Pitt, A. Amlot, R. Heffernan, C. Rubin, G. J. Smith, L. E.

A systematic review of psychological factors influencing attitudes and intentions toward, and uptake of, Covid-19 vaccines in adolescents

  • Adolescents
  • Adults
  • COVID-19
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Ilboudo, D. P. Simpore, A. Sawadogo, J. Ouattara, A. K. Ouedraogo, A. R. Zongo, L. Yonli, A. T. Zoure, A. A. Zohoncon, T. M. Djigma, F. W. Obiri-Yeboah, D. Ouedraogo, C. M. Simpore, J.

Acceptance, hesitancy, and ethical challenges of the COVID-19 vaccine in sub-Saharan Africa: a systematic review and meta-analysis

  • Africa
  • Adults
  • Healthcare workers
  • COVID-19
  • Acceptance
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Carlson, A. L. Althouse, J. Ahmed, N. Nazari, M. A. Alkaissi, H.

Acquired hemophilia A following SARS-CoV-2 infection and vaccination: clinical summary and insights

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Cao, Q. Du, S. Yang, K. Liu, M. Xiao, L. Wang, Q. Fu, J. Zhu, H.

Assessing the impact of SARS-CoV-2 infection and vaccination on fertility and assisted reproductive techniques outcomes: an umbrella review

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Danysz, M. De Aguiar, R. C. Pindolia, H. Stuart, B. Spensley, K. Ashmore, E. Frumento, N. Haouidji-Javaux, N. Hutchinson, C. Iles, R. Lau, S. Rolt, J. Uwenedi, G. Wagg, H. Barnes, E. Lim, S. H. Richter, A. Willicombe, M.

Association between COVID-19 vaccine immunogenicity and protection against infection and severe disease in clinically vulnerable patient populations: a systematic review and meta-analysis of observational studies

  • Adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2026 ∙ Faghir-Ganji, M. Abdolmohammadi, N. Ansari-Moghaddam, A. Askari, S. Eshrati, B.

COVID-19 vaccination and stroke risk: A systematic review and meta-analysis of ischemic and hemorrhagic events

  • All age groups
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Lotfi, M. Kaderali, L.

Data-driven strategies for model-informed decision-making during the COVID-19 pandemic: a systematic review

  • All age groups
  • COVID-19
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Alkhidir, M. Sridharan, K.

Efficacy and Safety of mRNA-Based COVID-19 Vaccines in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Calderon-Hernandez, C. C. Cahuapaza-Gutierrez, N. L. Villavicencio-Escudero, T. V. Ibarcena-Llerena, C. V. Quiroz-Narvaez, C. Coronado-Quispe, H. Y. Chaponan-Agip, N. V.

Endocrine disorders following SARS-CoV-2 vaccination. A comprehensive systematic review

  • All age groups
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
Loading...